Paolini John F. insider trades
Paolini John F. has filed 31 Form 4s with the SEC that we hold, all for Kiniksa Pharmaceuticals International, plc (KNSA), as CHIEF MEDICAL OFFICER. Across all of them we count 0 purchases worth $0 and 25 sales worth $13.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($8.0M). The largest single trade was a sale of 82,542 shares of Kiniksa Pharmaceuticals International, plc worth $3.1M, dated 2025-10-31. The first filing on our record is dated 2021-09-07 and the latest 2026-09-03.
Kiniksa Pharmaceuticals International, plc (KNSA)
CHIEF MEDICAL OFFICER · 31 filings · 25 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-11-07 | S, sale reported on Form 4 | 28,357 | $430.5K | 2022-11-09 | SEC |
| 2023-07-25 | S, sale reported on Form 4 | 7,632 | $150.3K | 2023-07-27 | SEC |
| 2023-07-25 | S, sale reported on Form 4 | 16,168 | $311.2K | 2023-07-27 | SEC |
| 2023-07-25 | S, sale reported on Form 4 | 5,200 | $93.7K | 2023-07-27 | SEC |
| 2023-09-05 | S, sale reported on Form 4 | 400 | $7.0K | 2023-09-06 | SEC |
| 2023-12-07 | S, sale reported on Form 4 | 13,017 | $229.6K | 2023-12-11 | SEC |
| 2023-12-07 | S, sale reported on Form 4 | 6,702 | $119.0K | 2023-12-11 | SEC |
| 2023-12-07 | S, sale reported on Form 4 | 1,501 | $26.7K | 2023-12-11 | SEC |
| 2023-12-07 | S, sale reported on Form 4 | 7,380 | $129.4K | 2023-12-11 | SEC |
| 2024-02-27 | S, sale reported on Form 4 | 10,156 | $213.6K | 2024-02-29 | SEC |
| 2024-03-01 | S, sale reported on Form 4 | 18,844 | $410.2K | 2024-03-05 | SEC |
| 2024-07-23 | S, sale reported on Form 4 | 7,924 | $208.9K | 2024-07-25 | SEC |
| 2024-07-23 | S, sale reported on Form 4 | 8,446 | $228.9K | 2024-07-25 | SEC |
| 2024-07-23 | S, sale reported on Form 4 | 100 | $2.8K | 2024-07-25 | SEC |
| 2024-07-23 | S, sale reported on Form 4 | 5,530 | $138.4K | 2024-07-25 | SEC |
| 2024-09-03 | S, sale reported on Form 4 | 59,214 | $1.5M | 2024-09-04 | SEC |
| 2024-09-03 | S, sale reported on Form 4 | 1,478 | $40.1K | 2024-09-04 | SEC |
| 2025-05-07 | S, sale reported on Form 4 | 200 | $5.4K | 2025-05-09 | SEC |
| 2025-08-06 | S, sale reported on Form 4 | 29,325 | $954.5K | 2025-08-08 | SEC |
| 2025-10-31 | S, sale reported on Form 4 | 82,542 | $3.1M | 2025-11-04 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 5,714 | $262.4K | 2026-03-04 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 22,223 | $997.4K | 2026-03-04 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 12,063 | $533.2K | 2026-03-04 | SEC |
| 2026-05-01 | S, sale reported on Form 4 | 37,327 | $2.0M | 2026-05-05 | SEC |
| 2026-05-01 | S, sale reported on Form 4 | 21,097 | $1.1M | 2026-05-05 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1741533) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
